Definium Therapeutics (DFTX) Non Operating Investment Income (2025 - 2026)
Definium Therapeutics (DFTX) reported Non Operating Investment Income of -$262000.0 for Q1 2026, down 2720.0% year-over-year from $10000.0 in Q1 2025, and down 397.73% on a QoQ basis from $88000.0 in Q4 2025.
Definium Therapeutics (DFTX) has 2 years of Non Operating Investment Income data on file, last reported at -$262000.0 in Q1 2026.
- Quarterly Non Operating Investment Income fell 2720.0% year-over-year to -$262000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $58000.0 (changed N/A YoY) and the FY2025 annual result came in at $330000.0, changed N/A from the prior year.
- Non Operating Investment Income declined to -$262000.0 in Q1 2026 per DFTX's latest filing, from $88000.0 in the prior quarter.
- Across five years, Non Operating Investment Income topped out at $196000.0 in Q3 2025 and bottomed at -$262000.0 in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 235,807.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 230,000.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Definium Therapeutics | 2.42 Bn | 2.06 Bn | - | -262,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -262,000.00 |
| Mar 31, 2026 | -262,000.00 |
| Dec 31, 2025 | 88,000.00 |
| Dec 31, 2025 | 88,000.00 |
| Sep 30, 2025 | 196,000.00 |
| Sep 30, 2025 | 196,000.00 |
| Jun 30, 2025 | 36,000.00 |
| Jun 30, 2025 | 36,000.00 |
| Mar 31, 2025 | 10,000.00 |
| Mar 31, 2025 | 10,000.00 |